Clinical Trial Update: Evaluation of Tolfenamic Acid in Individuals With PSP at 12-Weeks [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update evaluating tolfenamic acid in individuals with Progressive Supranuclear Palsy across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Supranuclear Palsy

Drugs mentioned

• Tolfenamic acid (tolfenamic acid)

Snippet

Sponsor: NeuroTau, Inc. | Conditions: Progressive Supranuclear Palsy | Phase 1, Phase 2 | Status: UNKNOWN